Paclitaxel Protects against Isoproterenol-Induced Damage in Rat Myocardium Its Heme-Oxygenase Mediated Role in Cardiovascular Research /

(1) Background: In cardiovascular applications, paclitaxel inhibits smooth muscle cell proliferation and migration and significantly reduces the occurrence of restenosis and target lesion revascularization. However, the cellular effects of paclitaxel in the myocardium are not well understood; (2) Me...

Teljes leírás

Elmentve itt :
Bibliográfiai részletek
Szerzők: Matusovits Danica
Murlasits Zsolt
Kupai Krisztina
Baráth Zoltán
Kang Hsu Lin
Osváth Péter
Szűcs Miklós
Priksz Dániel
Juhász Béla
Radák Zsolt
Várkonyi Tamás
Pávó Imre
Pósa Anikó
Dokumentumtípus: Cikk
Megjelent: 2023
Sorozat:ANTIOXIDANTS 12 No. 5
Tárgyszavak:
doi:10.3390/antiox12051129

mtmt:33856409
Online Access:http://publicatio.bibl.u-szeged.hu/27307
LEADER 02813nab a2200361 i 4500
001 publ27307
005 20230531082906.0
008 230531s2023 hu o 0|| Angol d
022 |a 2076-3921 
024 7 |a 10.3390/antiox12051129  |2 doi 
024 7 |a 33856409  |2 mtmt 
040 |a SZTE Publicatio Repozitórium  |b hun 
041 |a Angol 
100 1 |a Matusovits Danica 
245 1 0 |a Paclitaxel Protects against Isoproterenol-Induced Damage in Rat Myocardium  |h [elektronikus dokumentum] :  |b Its Heme-Oxygenase Mediated Role in Cardiovascular Research /  |c  Matusovits Danica 
260 |c 2023 
300 |a 13 
490 0 |a ANTIOXIDANTS  |v 12 No. 5 
520 3 |a (1) Background: In cardiovascular applications, paclitaxel inhibits smooth muscle cell proliferation and migration and significantly reduces the occurrence of restenosis and target lesion revascularization. However, the cellular effects of paclitaxel in the myocardium are not well understood; (2) Methods: Wistar rats were divided into four groups: control (CTRL), isoproterenol (ISO) treated (1 mg/kg) and two groups treated with paclitaxel (PAC), which was administrated (10 mg/kg/day) for 5 days by gavage/per os alone or in combination (ISO + PAC) 3 weeks after ISO treatment. Ventricular tissue was harvested 24 h later for measurements of heme oxygenase (HO-1), reduced glutathione (GSH), oxidized glutathione (GSSG), superoxide dismutase (SOD), NF-κB, TNF-α and myeloperoxidase (MPO); (3) Results: HO-1 protein concentration, HO-1 activity, SOD protein concentration and total glutathione significantly decreased in response to ISO treatment. When PAC was administered in conjunction with ISO, HO-1, SOD concentration and total glutathione were not different from control levels. MPO activity, NF-κB concentration and TNF-α protein concentration were significantly increased in the ISO-only group, while the levels of these molecules were restored when PAC was co-administered; (4) Conclusions: Oral administration of PAC can maintain the expression of important antioxidants, anti-inflammatory molecules, HO-1, SOD and GSH, and suppress the production of TNF-α, MPO and NF-κB, which are involved in myocardial damage. The principal component of this cellular defense seems to be the expression of HO-1. 
650 4 |a Klinikai orvostan 
700 0 1 |a Murlasits Zsolt  |e aut 
700 0 1 |a Kupai Krisztina  |e aut 
700 0 1 |a Baráth Zoltán  |e aut 
700 0 1 |a Kang Hsu Lin  |e aut 
700 0 1 |a Osváth Péter  |e aut 
700 0 1 |a Szűcs Miklós  |e aut 
700 0 1 |a Priksz Dániel  |e aut 
700 0 1 |a Juhász Béla  |e aut 
700 0 1 |a Radák Zsolt  |e aut 
700 0 1 |a Várkonyi Tamás  |e aut 
700 0 1 |a Pávó Imre  |e aut 
700 0 1 |a Pósa Anikó  |e aut 
856 4 0 |u http://publicatio.bibl.u-szeged.hu/27307/1/Matusovits.pdf  |z Dokumentum-elérés